HIV & Menopause · Care pathway
Specialized menopause care, prepared around your HIV care
Eight short steps build a clear summary of your ART, symptoms, risks and preferences. A licensed Kindr clinician can then evaluate you, while your HIV care team stays at the center of your care.
Answers on this page live only in this browser tab. They are not saved, not sent to Kindr, and disappear when you close or refresh the page. No advertising or analytics trackers run here. Anything you later choose to share in a clinical intake is protected health information handled under HIPAA, and is shared with your HIV clinician only with your permission.
- 1Privacy
- 2HIV care
- 3Periods
- 4Symptoms
- 5Health risks
- 6Medicines
- 7Preferences
- 8Your summary
Step 1 of 8
Privacy
This pathway is for women and people assigned female at birth living with HIV who are noticing perimenopause or menopause changes. It takes about 5 minutes.
- HIV is not a reason, on its own, to avoid hormone therapy.
- Your ART is reviewed for interactions; you should not need to change it.
- Every treatment decision is made by a licensed clinician.
If you have chest pain, sudden severe headache, leg swelling with breathlessness, or thoughts of harming yourself, call 911 or 988 now.
How this pathway works
1. You prepare privately
The steps above organize the details clinicians need most: your ART, recent HIV markers, menstrual pattern, symptom burden, bone and heart risks, and what kind of treatment you want to discuss.
2. A licensed clinician evaluates you
In the Kindr clinical intake, a licensed clinician reviews your history, checks every ART and hormone combination for interactions, and discusses options. Transdermal estradiol is generally preferred when hormone therapy is appropriate; non-hormonal options are chosen with your regimen in mind.
3. Your HIV care team stays central
Your HIV clinician keeps managing your ART and viral load. With your permission, your menopause plan is shared so both teams can coordinate. You will not be asked to change ART for menopause care.
Read the full HIV and menopause guide · Hormone therapy with HIV · Non-hormonal options
WRITTEN & MEDICALLY REVIEWED BY
Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team, led by Kevin Wolfe, CMO
Kindr’s clinical content is written and reviewed by board-certified clinicians who prescribe hormone therapy every day across all 50 states — menopause-focused physicians, nurse practitioners, and pharmacists working under Kindr Health, Inc.’s organizational clinical oversight. Every page is checked against current NAMS and ACOG guidance, FDA labeling, and the primary literature before publication, then re-reviewed on a rolling schedule when guidance changes.
Organizational NPI 1609792902 · Last reviewed October 4, 2026 · Editorial policy
Educational content only — not a substitute for individual medical advice, diagnosis, or treatment.
SOURCES & REFERENCES
Every clinical claim on this page is sourced.
- HIV Drug Interactions Checker — University of Liverpool. www.hiv-druginteractions.org/checker
- Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV: Women with HIV — U.S. Department of Health and Human Services (DHHS), Clinicalinfo.HIV.gov. clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/women-hiv
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society (2022) — The Menopause Society (formerly NAMS). www.menopause.org/docs/default-source/professional/nams-2022-hormone-therapy-position-statement.pdf